James Arthur Bristol serves as Executive at Deciphera Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, James Arthur Bristol has executed 55 insider transactions totaling $9.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 13, 2019 involved exercising options for 2,922 shares valued at $5.5K.
James Arthur Bristol currently holds 37,762 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Arthur Bristol has been a net seller of DCPH stock. They have purchased $82.8K and sold $9.1M worth of shares.
James Arthur Bristol's most recent insider trade was on Feb 13, 2019, when they sold 2,922 shares at $1.89 per share.
Get notified when new Form 4 filings are submitted
| $28.00 |
| Discretionary |
| Feb 12, 2019 | DCPH | $1.1K | Option Exercise | 600 | $1.89 | Discretionary |
| Feb 5, 2019 | DCPH | $4.9K | Option Exercise | 2,595 | $1.89 | Discretionary |
| Feb 5, 2019 | DCPH | $72.7K | Sale | 2,595 | $28.02 | Discretionary |